• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几丁质酶和可溶性白细胞介素-2受体:结节病严重程度的两种标志物比较。

Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.

作者信息

Bargagli Elena, Bianchi Nicola, Margollicci Maria, Olivieri Carmela, Luddi Alice, Coviello Giuseppe, Grosso Salvatore, Rottoli Paola

机构信息

Department of Clinical Medicine and Immunology, Respiratory Diseases Section, Siena University, Italy.

出版信息

Scand J Clin Lab Invest. 2008;68(6):479-83. doi: 10.1080/00365510701854975.

DOI:10.1080/00365510701854975
PMID:18609101
Abstract

BACKGROUND

Sarcoidosis is a multisystemic granulomatous disease with an unpredictable clinical course characterized by accumulation of activated proliferating T lymphocytes and mononuclear phagocytes in affected organs.

AIMS AND METHODS

The aims of this study were to describe the clinical, radiological and immunological features of a population of sarcoidosis patients followed at the Sarcoidosis Regional Centre in Siena and to analyse chitotriosidase and sIL-2R concentrations in serum of these patients in order to understand their potential as disease markers.

RESULTS

Chitotriosidase and sIL-2R concentrations in serum of sarcoidosis patients were found to be significantly higher than in healthy controls (p<0.01) and a positive correlation between the two markers was documented for the first time. Moreover, chitotriosidase and sIL-2R were expressed differently in different radiographic stages of the disease.

CONCLUSION

Chitotriosidase and sIL-2R are two markers of sarcoidosis of different origin, the values of which show a correlation in these patients; they are easily detectable in serum and could be useful clinical markers of progression.

摘要

背景

结节病是一种多系统肉芽肿性疾病,临床病程不可预测,其特征是受累器官中活化增殖的T淋巴细胞和单核吞噬细胞聚集。

目的与方法

本研究的目的是描述在锡耶纳结节病区域中心随访的一组结节病患者的临床、放射学和免疫学特征,并分析这些患者血清中的几丁质酶和可溶性白细胞介素-2受体(sIL-2R)浓度,以了解它们作为疾病标志物的潜力。

结果

发现结节病患者血清中的几丁质酶和sIL-2R浓度显著高于健康对照组(p<0.01),并且首次记录到这两种标志物之间存在正相关。此外,几丁质酶和sIL-2R在疾病的不同放射学阶段表达不同。

结论

几丁质酶和sIL-2R是两种来源不同的结节病标志物,在这些患者中其值呈现相关性;它们在血清中易于检测,可能是有用的疾病进展临床标志物。

相似文献

1
Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.几丁质酶和可溶性白细胞介素-2受体:结节病严重程度的两种标志物比较。
Scand J Clin Lab Invest. 2008;68(6):479-83. doi: 10.1080/00365510701854975.
2
Human chitotriosidase: a potential new marker of sarcoidosis severity.人几丁质酶:结节病严重程度的一种潜在新标志物。
Respiration. 2008;76(2):234-8. doi: 10.1159/000134009. Epub 2008 May 19.
3
[Serum soluble IL-2 receptor level in patients with sarcoidosis].[结节病患者血清可溶性白细胞介素-2受体水平]
Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Mar;29(3):316-21.
4
Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.血浆壳三糖苷酶和 CCL18 作为肉样瘤病中肉芽肿性巨噬细胞的替代标志物。
Clin Chim Acta. 2010 Jan;411(1-2):31-6. doi: 10.1016/j.cca.2009.09.034. Epub 2009 Oct 4.
5
Chitotriosidase activity in sarcoidosis and some other pulmonary diseases.结节病及其他一些肺部疾病中的壳三糖苷酶活性
Scand J Clin Lab Invest. 2009;69(5):575-8. doi: 10.1080/00365510902829362.
6
Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.结节病和特发性肺纤维化患者血液中的可溶性白细胞介素-2受体
Sarcoidosis. 1994 Sep;11(2):102-9.
7
Chitotriosidase activity in patients with interstitial lung diseases.间质性肺疾病患者的壳三糖苷酶活性
Respir Med. 2007 Oct;101(10):2176-81. doi: 10.1016/j.rmed.2007.05.008. Epub 2007 Jul 13.
8
Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.血清可溶性白细胞介素-2受体作为某些自身免疫性疾病中淋巴细胞活化的标志物。免疫抑制治疗的效果。
Roum Arch Microbiol Immunol. 2001 Jul-Sep;60(3):183-201.
9
Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.黑色素瘤患者血清中可溶性白细胞介素-2受体、细胞间黏附分子-1和白细胞介素-10水平
Br J Cancer. 2000 Oct;83(7):847-52. doi: 10.1054/bjoc.2000.1402.
10
Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis.结节病和肺结核患者血清中的壳三糖苷酶活性。
Respiration. 2007;74(5):548-52. doi: 10.1159/000100555. Epub 2007 Mar 7.

引用本文的文献

1
Risk Indicators of Sarcoidosis Evolution-Unified Protocol (RISE-UP): protocol for a multi-centre, longitudinal, observational study to identify clinical features that are predictive of sarcoidosis progression.结节病演变风险指标-统一方案(RISE-UP):一项多中心、纵向、观察性研究协议,旨在确定预测结节病进展的临床特征。
BMJ Open. 2023 Apr 3;13(4):e071607. doi: 10.1136/bmjopen-2023-071607.
2
Clinical phenotyping in sarcoidosis management.结节病管理中的临床表型分析。
Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(2):e2021007. doi: 10.36141/svdld.v38i2.10423. Epub 2021 Jun 28.
3
Serum B cell activating factor (BAFF) and sarcoidosis activity.
血清B细胞活化因子(BAFF)与结节病活动度
Arch Rheumatol. 2020 Sep 11;36(1):72-79. doi: 10.46497/ArchRheumatol.2021.8013. eCollection 2021 Mar.
4
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series.特发性肺纤维化(IPF)患者肿瘤标志物的系统评价与荟萃分析以及一项意大利前瞻性真实病例系列中肿瘤标志物的系列变化
Cancers (Basel). 2021 Jan 31;13(3):539. doi: 10.3390/cancers13030539.
5
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.结节病的诊断和预后的生物标志物:当前的应用和未来的前景。
Front Immunol. 2020 Jul 14;11:1443. doi: 10.3389/fimmu.2020.01443. eCollection 2020.
6
Biological role of the soluble interleukin-2 receptor in sarcoidosis.可溶性白细胞介素-2受体在结节病中的生物学作用。
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):122-129. doi: 10.36141/svdld.v34i2.5369. Epub 2017 Apr 28.
7
Lung CD4+ Vα2.3+ T-cells in sarcoidosis cohorts with Löfgren's syndrome.结节病伴 Löfgren 综合征患者肺脏 CD4+ Vα2.3+ T 细胞。
Respir Res. 2020 Feb 28;21(1):61. doi: 10.1186/s12931-020-1327-0.
8
BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.BAL 标志物面板用于间质性肺疾病的鉴别诊断。
Clin Exp Med. 2020 May;20(2):207-216. doi: 10.1007/s10238-020-00608-5. Epub 2020 Jan 22.
9
Trained Innate Immunity Not Always Amicable.先天免疫并非总是友善的。
Int J Mol Sci. 2019 May 24;20(10):2565. doi: 10.3390/ijms20102565.
10
Identification of Active Sarcoidosis Using Chitotriosidase and Angiotensin-Converting Enzyme.采用壳三糖苷酶和血管紧张素转化酶鉴定活动性结节病。
Lung. 2019 Jun;197(3):295-302. doi: 10.1007/s00408-019-00219-2. Epub 2019 Mar 19.